======= BUD31 =======
== Gene Information ==
* **Official Symbol**: BUD31
* **Official Name**: BUD31 homolog
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=8896|8896]]
* **UniProt**: [[https://www.uniprot.org/uniprot/P41223|P41223]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=BUD31&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20BUD31|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/603477|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: N/A
|G10|
|positive regulation of androgen receptor activity|
|nuclear hormone receptor binding|
|U2-type catalytic step 2 spliceosome|
|nuclear receptor transcription coactivator activity|
|spliceosomal complex|
|nuclear chromatin|
|positive regulation of DNA-binding transcription factor activity|
|mRNA splicing, via spliceosome|
|RNA splicing, via transesterification reactions with bulged adenosine as nucleophile|
|RNA splicing, via transesterification reactions|
|RNA splicing|
|regulation of DNA-binding transcription factor activity|
|mRNA processing|
|mRNA metabolic process|
|RNA processing|
|positive regulation of nucleic acid-templated transcription|
|positive regulation of RNA biosynthetic process|
|positive regulation of signal transduction|
|RNA metabolic process|
|positive regulation of RNA metabolic process|
|positive regulation of molecular function|
|positive regulation of cell communication|
|positive regulation of signaling|
|positive regulation of nucleobase-containing compound metabolic process|
|positive regulation of macromolecule biosynthetic process|
|positive regulation of cellular biosynthetic process|
|gene expression|
|positive regulation of biosynthetic process|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp33|Rotenone 2μM R00 exp33]]|-1.78|
|[[:results:exp6|Bortezomib 0.005μM R00 exp6]]|1.72|
|[[:results:exp301|VER-155008 3.9μM R06 exp301]]|1.77|
|[[:results:exp481|Ethambutol 25μM R08 exp481]]|1.83|
|[[:results:exp36|TRAIL 50ng/ml R00 exp36]]|1.85|
|[[:results:exp210|LB-100 2μM R05 exp210]]|2.31|
|[[:results:exp277|Curcumin 6.5μM R06 exp277]]|2.39|
^Gene^Correlation^
|[[:human genes:p:prim1|PRIM1]]|0.529|
|[[:human genes:p:psmb4|PSMB4]]|0.409|
Global Fraction of Cell Lines Where Essential: 737/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|1/1|
|909776.0|1/1|
|bile duct|28/28|
|blood|27/28|
|bone|26/26|
|breast|32/33|
|central nervous system|56/56|
|cervix|4/4|
|colorectal|17/17|
|esophagus|13/13|
|fibroblast|1/1|
|gastric|16/16|
|kidney|21/21|
|liver|20/20|
|lung|75/75|
|lymphocyte|16/16|
|ovary|26/26|
|pancreas|24/24|
|peripheral nervous system|16/16|
|plasma cell|15/15|
|prostate|1/1|
|skin|24/24|
|soft tissue|9/9|
|thyroid|2/2|
|upper aerodigestive|22/22|
|urinary tract|29/29|
|uterus|5/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 193
* **Expression level (log2 read counts)**: 5.42
{{:chemogenomics:nalm6 dist.png?nolink |}}